NFKB1 and neoplasm: In addition, it has been shown that LZAP acts as a novel tumor suppressor in primary head and neck cancers by specifically inhibiting NF-κB signaling and that decreased LZAP expression promotes cellular transformation, xenograft tumor growth, and xenograft tumor vascularity [8].